Recital 6, Decision_act (EU) 2009/980

In force

Following an application from Provexis Natural Products Ltd, submitted on 7 January 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of water-soluble tomato concentrate (WSTC) I and II on the blood platelet activity in healthy people (Question No EFSA-Q-2009-00229) [The EFSA Journal (2009) 1101, pp. 1-15.]. The claim proposed by the applicant was worded as follows: ‘Helps to maintain a healthy blood flow and benefits circulation’.